savetrial.org
Recruitment finished | SAVE
http://www.savetrial.org/articles/2014/03/05/recruitment_finished
Recruitment finished at the end of November 2013 and the final number of participants is 2717. Thank you to all who have helped make this possible and we wish all investigators and participants every success with the follow up visits.
savetrial.org
Results | SAVE
http://www.savetrial.org/results
The results of the SAVE study were announced on August 28th 2016 at the European Society of Cardiology Conference and published simultaneously in the New England Journal of Medicine. For more information regarding the results, watch the video below or see Findings from Research.
savetrial.org
Organisation | SAVE
http://www.savetrial.org/organisation
SAVE is a collaborative research project being undertaken in the spirit of international co-operation to answer an important clinical and public health question in a timely, effective and efficient manner. International Coordinating Centre (ICC). Responsible for overall coordination of the study; The ICC is based at the Adelaide Institute for Sleep Health. Adelaide, South Australia. Dr Emma Heeley (Chair), Professor Doug McEvoy, Professor Craig Anderson, Associate Professor Nick Antic.
savetrial.org
Study Overview | SAVE
http://www.savetrial.org/page/view_by_id/12
Although obstructive sleep apnea (OSA) is a very common condition that is associated with an increased risk of cardiovascular disease (CVD), there is much uncertainty over the effectiveness of treatment with nasal continuous positive airway pressure (CPAP) for the prevention of CVD. Only a large-scale clinical trial could resolve this uncertainty and if positive, radically change clinical practice so that screening for OSA is part of the routine CVD risk assessment.
savetrial.org
SAVE
http://www.savetrial.org/es/home_page
Información de los participantes. Latest News and Events. Los resultados anunciados y publicados! Para más información, ver Resultados. SLEEP APNEA CARDIOVASCULAR ENDPOINTS STUDY (SAVE). SAVE es un estudio multicéntrico, aleatorizado y controlado para determinar los efectos del uso de la CPAP en la prevención de enfermedades cardiovasculares en pacientes de alto riesgo con Síndrome de Apneas del Sueño (SAHS) moderado-grave. Véase Study Overview. Los resultados anunciados y publicados!
savetrial.org
SAVE
http://www.savetrial.org/cn/home_page
Latest News and Events. 22914;需更多的信息,请参见结果。 SAVE研究是一项多中心,随机,对照试验,旨在确定运用持续气道正压通气(CPAP)预防患有中重度阻塞性睡眠呼吸暂停(OSA) 的高危患者的心血管&...19968;项由睡眠及心血管专家参与的关键性研究项目,其目的在于给大范围及全球疾病负担持续增加区域内的临床决...32467;果已公布并发表. 22914;需更多的信息,请参见 结果. SAVE研究领域. 20351;用下列链接登录:. Visit the Respironics website.
savetrial.org
SAVE
http://www.savetrial.org/home_page
Latest News and Events. Results announced and published! For more information, see Results. Sleep Apnea Cardiovascular Endpoints Study (SAVE). Save is a multi-centre, randomised, controlled trial to determine the effects of nasal continuous positive airway pressure (CPAP) in preventing cardiovascular (CV) disease in high risk patients with moderate-severe obstructive sleep apnea (OSA). See Study Overview. Results announced and published! For more information, see Results. Visit the Respironics website.
savetrial.org
Participant Information | SAVE
http://www.savetrial.org/participant_information
Who are we looking for? What is the SAVE study? SAVE is an international study, attempting to discover if the use of CPAP. Can reduce the risk of heart attack, stroke or heart failure in patients with OSA. Screening and recruitment for SAVE is now complete and follow up visits will be continuing until the end of 2015. Those who met the entry requirements.
savetrial.org
Partnerships | SAVE
http://www.savetrial.org/partnerships
Adelaide Institute for Sleep Health. George Institute for Global Health. SAVE is endorsed by:. Australasian Sleep Trials Network. SAVE is approved by:. The Australasian Stroke Trials Network. The SAVE study is made possible by donations and grants from study sponsor partners:. Australian Government, National Health and Medical Research Council. Fisher and Paykel Healthcare. The SAVE study is supported by generous equipment donations from:.
savetrial.org
SAVE
http://www.savetrial.org/pt/home_page
Latest News and Events. Os resultados anunciados e publicados! Para mais informações, consulte Resultados. Apnea do sono endpoints cardiovasculares do estudo (save). O estudo SAVE é multicêntrico, aberto, randomizado e controlado de tratamento da apnéia obstrutiva do sono com pressão positiva das vias aéreas superiores (CPAP) para prevenir doenças cardiovasculares (CV) e pacientes de alto risco com apnéia obstrutiva do sono (AOS) moderada-grave. Consulte o Estudo Overview. Visit the Respironics website.